Company Profiles

driven by the PitchBook Platform

Diasome Pharmaceuticals

Description

Provider of insulin-based therapies for the treatment of diabetes. The company uses nano-technology based cell targeting system to preferentially deliver insulin to specific sites in the body for the treatment of Type 1 and Type 2 diabetes.

2004

Founded

PRIVATE

Status

Series B

Latest Deal Type

$12.9M

Latest Deal Amount

$13.2M

Total Amount Raised

3

Investors

Description

Provider of insulin-based therapies for the treatment of diabetes. The company uses nano-technology based cell targeting system to preferentially deliver insulin to specific sites in the body for the treatment of Type 1 and Type 2 diabetes.

Website:

www.diasomepharmaceuticals.com

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Drug Discovery

Other Industries

Other Healthcare
Other Pharmaceuticals and Biotechnology

Primary Office

10000 Cedar Avenue Suite 6 Cleveland, OH 44106United States +1 (216) 444-7110
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Diasome Pharmaceuticals's full profile, request a free trial.

Diasome Pharmaceuticals Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Diasome Pharmaceuticals Investors (3)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
Devon Park BioventuresVenture CapitalMinority000 0000000 0000
L2 PharmaMinority000 0000000 0000
Quaker PartnersVenture CapitalMinority000 0000000 0000
Devon Park Bioventures Venture Capital
L2 Pharma
Quaker Partners Venture Capital

Diasome Pharmaceuticals Executive Team (6)

NameTitleBoard
Seat
Contact
Info
Robert GehoChief Executive Officer, Co-Founder & Board Member
Helga KautskyChief Financial Officer
Stephen Charles Ph.DChief Technology Officer
W. Blair Geho Ph.DCo-Founder, Chief Scientific Officer & Board Member
John LauHead, Chemistry
Robert Geho Chief Executive Officer, Co-Founder & Board Member
Helga Kautsky Chief Financial Officer
Stephen Charles Ph.D Chief Technology Officer
W. Blair Geho Ph.D Co-Founder, Chief Scientific Officer & Board Member
John Lau Head, Chemistry

Diasome Pharmaceuticals Board Members (8)

NameRepresentingRoleSinceContact
Info
Alexander FlemingSelfBoard Member000 0000
Arthur Rubenstein MDSelfBoard Member000 0000
David KingQuaker PartnersVenture Partner000 0000
Devang Kantesaria MDDevon Park BioventuresGeneral Partner000 0000
Frank McCaneySelfBoard Member000 0000
Alexander Fleming Board Member Self
Arthur Rubenstein MD Board Member Self
David King Venture Partner Quaker Partners
Devang Kantesaria MD General Partner Devon Park Bioventures
Frank McCaney Board Member Self
Request full access to PitchBook